Drug Shortage Report for DEPO-TESTOSTERONE INJ 100MG/ML
Report ID | 134289 |
Drug Identification Number | 00030783 |
Brand name | DEPO-TESTOSTERONE INJ 100MG/ML |
Common or Proper name | DEPO-TESTOSTERONE |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE CYPIONATE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10mL vial |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-07-05 |
Estimated end date | 2023-05-15 |
Actual end date | 2023-05-02 |
Shortage status | Resolved |
Updated date | 2023-05-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-05-03 | French | Compare |
v12 | 2023-05-03 | English | Compare |
v11 | 2023-04-21 | French | Compare |
v10 | 2023-04-21 | English | Compare |
v9 | 2021-12-10 | French | Compare |
v8 | 2021-12-10 | English | Compare |
v7 | 2021-07-06 | English | Compare |
v6 | 2021-07-05 | French | Compare |
v5 | 2021-07-05 | English | Compare |
v4 | 2021-06-02 | French | Compare |
v3 | 2021-06-02 | English | Compare |
v2 | 2021-02-17 | French | Compare |
v1 | 2021-02-17 | English | Compare |
Showing 1 to 13 of 13